Mary Wilson
Well-known member
July 2, 2021
By Joseph Rodgers, Filippa Lentzos, Gregory D. Koblentz, Minh Ly
Since 2001, biological risks—from terror attacks involving anthrax letters to outbreaks of new and re-emerging infectious diseases like SARS, Ebola, H5N1 avian influenza, MERS, and Zika—have been galvanizing a global construction boom of research labs meant for work on the deadliest pathogens. These biosafety level 4 labs (BSL-4) are the kind of facilities where researchers have to work in protective gear resembling spacesuits and decontaminate once they finish. Today, 23 countries have built 59 of these state-of-the-art labs, part of a trend that seems unlikely to stop soon. As scientists seek to better understand viruses like the one that causes COVID-19, they will likely need more labs tailor-made for work with risky germs.
... only three of the countries with BSL-4 labs have policies on dual-use research—meaning that the vast majority of countries with these labs do not conduct oversight of the type of high-risk, gain-of-function research that makes pathogens more dangerous and that has been a central feature in the COVID-19 origins debate.
https://thebulletin.org/2021/07/how...archingMostDangerousPathogensAreSafe_07012021
By Joseph Rodgers, Filippa Lentzos, Gregory D. Koblentz, Minh Ly
Since 2001, biological risks—from terror attacks involving anthrax letters to outbreaks of new and re-emerging infectious diseases like SARS, Ebola, H5N1 avian influenza, MERS, and Zika—have been galvanizing a global construction boom of research labs meant for work on the deadliest pathogens. These biosafety level 4 labs (BSL-4) are the kind of facilities where researchers have to work in protective gear resembling spacesuits and decontaminate once they finish. Today, 23 countries have built 59 of these state-of-the-art labs, part of a trend that seems unlikely to stop soon. As scientists seek to better understand viruses like the one that causes COVID-19, they will likely need more labs tailor-made for work with risky germs.
... only three of the countries with BSL-4 labs have policies on dual-use research—meaning that the vast majority of countries with these labs do not conduct oversight of the type of high-risk, gain-of-function research that makes pathogens more dangerous and that has been a central feature in the COVID-19 origins debate.
https://thebulletin.org/2021/07/how...archingMostDangerousPathogensAreSafe_07012021